RESUMEN
Peroxisomes are involved in multiple metabolic processes, including fatty acid oxidation, ether lipid synthesis, and reactive oxygen species (ROS) metabolism. Recent studies suggest that peroxisomes are critical mediators of cellular responses to various forms of stress, including oxidative stress, hypoxia, starvation, cold exposure, and noise. As dynamic organelles, peroxisomes can modulate their proliferation, morphology, and movement within cells, and engage in crosstalk with other organelles in response to external cues. Although peroxisome-derived hydrogen peroxide has a key role in cellular signaling related to stress, emerging studies suggest that other products of peroxisomal metabolism, such as acetyl-CoA and ether lipids, are also important for metabolic adaptation to stress. Here, we review molecular mechanisms through which peroxisomes regulate metabolic and environmental stress.
Asunto(s)
Estrés Oxidativo , Peroxisomas , Metabolismo de los Lípidos , Oxidación-Reducción , Peroxisomas/metabolismo , Especies Reactivas de Oxígeno/metabolismoRESUMEN
The Mediator complex relays regulatory signals from gene-specific transcription factors to the basal transcriptional machinery. However, the role of individual Mediator subunits in different tissues remains unclear. Here, we demonstrate that MED19 is essential for adipogenesis and maintenance of white adipose tissue (WAT) by mediating peroxisome proliferator-activated receptor gamma (PPARγ) transcriptional activity. MED19 knockdown blocks white adipogenesis, but not brown adipogenesis or C2C12 myoblast differentiation. Adipose-specific MED19 knockout (KO) in mice results in a striking loss of WAT, whitening of brown fat, hepatic steatosis, and insulin resistance. Inducible adipose-specific MED19 KO in adult animals also results in lipodystrophy, demonstrating its requirement for WAT maintenance. Global gene expression analysis reveals induction of genes involved in apoptosis and inflammation and impaired expression of adipose-specific genes, resulting from decreased PPARγ residency on adipocyte gene promoters and reduced association of PPARγ with RNA polymerase II. These results identify MED19 as a crucial facilitator of PPARγ-mediated gene expression in adipose tissue.
Asunto(s)
Tejido Adiposo Blanco/metabolismo , Expresión Génica/genética , Complejo Mediador/metabolismo , PPAR gamma/metabolismo , Adipocitos Marrones/metabolismo , Adipogénesis , Animales , Diferenciación Celular , Humanos , RatonesRESUMEN
Hepatic lipid homeostasis is controlled by a coordinated regulation of various metabolic pathways involved in de novo synthesis, uptake, storage, and catabolism of lipids. Disruption of this balance could lead to hepatic steatosis. Peroxisomes play an essential role in lipid metabolism, yet their importance is often overlooked. In a recent study, we demonstrated a role for hepatic peroxisomal ß-oxidation in autophagic degradation of lipid droplets. ACOX1 (acyl-Coenzyme A oxidase 1, palmitoyl), the rate-limiting enzyme of peroxisomal ß-oxidation, increases with fasting or high-fat diet (HFD). Liver-specific acox1 knockout (acox1-LKO) protects mice from hepatic steatosis induced by starvation or HFD via induction of lipophagy. Mechanistically, we showed that hepatic ACOX1 deficiency decreases the total cytosolic acetyl-CoA levels, which leads to reduced acetylation of RPTOR/RAPTOR, a component of MTORC1, which is a key regulator of macroautophagy/autophagy. These results identify peroxisome-derived acetyl-CoA as a critical metabolic regulator of autophagy that controls hepatic lipid homeostasis.
Asunto(s)
Autofagia , Hígado/metabolismo , Peroxisomas/metabolismo , Proteína Reguladora Asociada a mTOR/metabolismo , Serina-Treonina Quinasas TOR/metabolismo , Acetilcoenzima A/metabolismo , Acetilación , Animales , Humanos , Gotas Lipídicas/metabolismo , Ratones Noqueados , Modelos Biológicos , Oxidación-ReducciónRESUMEN
Autophagy is activated by prolonged fasting but cannot overcome the ensuing hepatic lipid overload, resulting in fatty liver. Here, we describe a peroxisome-lysosome metabolic link that restricts autophagic degradation of lipids. Acyl-CoA oxidase 1 (Acox1), the enzyme that catalyzes the first step in peroxisomal ß-oxidation, is enriched in liver and further increases with fasting or high-fat diet (HFD). Liver-specific Acox1 knockout (Acox1-LKO) protected mice against hepatic steatosis caused by starvation or HFD due to induction of autophagic degradation of lipid droplets. Hepatic Acox1 deficiency markedly lowered total cytosolic acetyl-CoA levels, which led to decreased Raptor acetylation and reduced lysosomal localization of mTOR, resulting in impaired activation of mTORC1, a central regulator of autophagy. Dichloroacetic acid treatment elevated acetyl-CoA levels, restored mTORC1 activation, inhibited autophagy, and increased hepatic triglycerides in Acox1-LKO mice. These results identify peroxisome-derived acetyl-CoA as a key metabolic regulator of autophagy that controls hepatic lipid homeostasis.
Asunto(s)
Acetilcoenzima A/metabolismo , Acil-CoA Oxidasa/fisiología , Autofagia , Ácidos Grasos/química , Hígado Graso/patología , Diana Mecanicista del Complejo 1 de la Rapamicina/metabolismo , Peroxisomas/química , Acetilación , Animales , Proteína 5 Relacionada con la Autofagia/fisiología , Dieta Alta en Grasa/efectos adversos , Ayuno , Hígado Graso/etiología , Hígado Graso/metabolismo , Femenino , Masculino , Diana Mecanicista del Complejo 1 de la Rapamicina/genética , Ratones , Ratones Noqueados , Mitocondrias/metabolismo , Oxidación-Reducción , Peroxisomas/metabolismo , Proteína Reguladora Asociada a mTOR/genética , Proteína Reguladora Asociada a mTOR/metabolismoRESUMEN
Peroxisomes perform essential functions in lipid metabolism, including fatty acid oxidation and plasmalogen synthesis. Here, we describe a role for peroxisomal lipid metabolism in mitochondrial dynamics in brown and beige adipocytes. Adipose tissue peroxisomal biogenesis was induced in response to cold exposure through activation of the thermogenic coregulator PRDM16. Adipose-specific knockout of the peroxisomal biogenesis factor Pex16 (Pex16-AKO) in mice impaired cold tolerance, decreased energy expenditure, and increased diet-induced obesity. Pex16 deficiency blocked cold-induced mitochondrial fission, decreased mitochondrial copy number, and caused mitochondrial dysfunction. Adipose-specific knockout of the peroxisomal ß-oxidation enzyme acyl-CoA oxidase 1 (Acox1-AKO) was not sufficient to affect adiposity, thermogenesis, or mitochondrial copy number, but knockdown of the plasmalogen synthetic enzyme glyceronephosphate O-acyltransferase (GNPAT) recapitulated the effects of Pex16 inactivation on mitochondrial morphology and function. Plasmalogens are present in mitochondria and decreased with Pex16 inactivation. Dietary supplementation with plasmalogens increased mitochondrial copy number, improved mitochondrial function, and rescued thermogenesis in Pex16-AKO mice. These findings support a surprising interaction between peroxisomes and mitochondria regulating mitochondrial dynamics and thermogenesis.
Asunto(s)
Tejido Adiposo/metabolismo , Frío , Lípidos/biosíntesis , Mitocondrias/metabolismo , Dinámicas Mitocondriales , Peroxisomas/metabolismo , Termogénesis , Acil-CoA Oxidasa/genética , Acil-CoA Oxidasa/metabolismo , Animales , Células COS , Chlorocebus aethiops , Células HEK293 , Humanos , Lípidos/genética , Ratones , Ratones Noqueados , Mitocondrias/genética , Peroxinas/genética , Peroxinas/metabolismo , Peroxisomas/genética , Plasmalógenos/farmacologíaRESUMEN
Ether lipids, such as plasmalogens, are peroxisome-derived glycerophospholipids in which the hydrocarbon chain at the sn-1 position of the glycerol backbone is attached by an ether bond, as opposed to an ester bond in the more common diacyl phospholipids. This seemingly simple biochemical change has profound structural and functional implications. Notably, the tendency of ether lipids to form non-lamellar inverted hexagonal structures in model membranes suggests that they have a role in facilitating membrane fusion processes. Ether lipids are also important for the organization and stability of lipid raft microdomains, cholesterol-rich membrane regions involved in cellular signaling. In addition to their structural roles, a subset of ether lipids are thought to function as endogenous antioxidants, and emerging studies suggest that they are involved in cell differentiation and signaling pathways. Here, we review the biology of ether lipids and their potential significance in human disorders, including neurological diseases, cancer, and metabolic disorders.
Asunto(s)
Éter/química , Metabolismo de los Lípidos , Lípidos/química , Animales , Enfermedad , HumanosRESUMEN
How the nuclear receptor PPARγ regulates the development of two functionally distinct types of adipose tissue, brown and white fat, as well as the browning of white fat, remains unclear. Our previous studies suggest that PexRAP, a peroxisomal lipid synthetic enzyme, regulates PPARγ signaling and white adipogenesis. Here, we show that PexRAP is an inhibitor of brown adipocyte gene expression. PexRAP inactivation promoted adipocyte browning, increased energy expenditure, and decreased adiposity. Identification of PexRAP-interacting proteins suggests that PexRAP function extends beyond its role as a lipid synthetic enzyme. Notably, PexRAP interacts with importin-ß1, a nuclear import factor, and knockdown of PexRAP in adipocytes reduced the levels of nuclear phospholipids. PexRAP also interacts with PPARγ, as well as PRDM16, a critical transcriptional regulator of thermogenesis, and disrupts the PRDM16-PPARγ complex, providing a potential mechanism for PexRAP-mediated inhibition of adipocyte browning. These results identify PexRAP as an important regulator of adipose tissue remodeling.
Asunto(s)
Proteínas de Unión al ADN/metabolismo , Regulación de la Expresión Génica , Deshidrogenasas del Alcohol de Azúcar/metabolismo , Termogénesis/genética , Factores de Transcripción/metabolismo , Adipocitos/metabolismo , Tejido Adiposo Pardo/metabolismo , Animales , Secuencia de Bases , Núcleo Celular/metabolismo , Perfilación de la Expresión Génica , Marcaje Isotópico , Ratones Endogámicos C57BL , Ratones Noqueados , PPAR gamma/metabolismo , Unión Proteica , Transporte de Proteínas , Grasa Subcutánea/metabolismo , Deshidrogenasas del Alcohol de Azúcar/genética , Transcripción GenéticaAsunto(s)
Mutación con Ganancia de Función , Genes Dominantes , Síndrome Hipereosinofílico/diagnóstico , Síndrome Hipereosinofílico/etiología , Enfermedades del Sistema Inmune/diagnóstico , Enfermedades del Sistema Inmune/etiología , Janus Quinasa 1/genética , Alelos , Femenino , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Genotipo , Mutación de Línea Germinal , Humanos , Síndrome Hipereosinofílico/tratamiento farmacológico , Enfermedades del Sistema Inmune/tratamiento farmacológico , Inmunomodulación/genética , Janus Quinasa 1/química , Masculino , Linaje , Fenotipo , Secuenciación del ExomaRESUMEN
The miniaturization, sophistication, proliferation, and accessibility of technologies are enabling the capture of more and previously inaccessible phenomena in Parkinson's disease (PD). However, more information has not translated into a greater understanding of disease complexity to satisfy diagnostic and therapeutic needs. Challenges include noncompatible technology platforms, the need for wide-scale and long-term deployment of sensor technology (among vulnerable elderly patients in particular), and the gap between the "big data" acquired with sensitive measurement technologies and their limited clinical application. Major opportunities could be realized if new technologies are developed as part of open-source and/or open-hardware platforms that enable multichannel data capture sensitive to the broad range of motor and nonmotor problems that characterize PD and are adaptable into self-adjusting, individualized treatment delivery systems. The International Parkinson and Movement Disorders Society Task Force on Technology is entrusted to convene engineers, clinicians, researchers, and patients to promote the development of integrated measurement and closed-loop therapeutic systems with high patient adherence that also serve to (1) encourage the adoption of clinico-pathophysiologic phenotyping and early detection of critical disease milestones, (2) enhance the tailoring of symptomatic therapy, (3) improve subgroup targeting of patients for future testing of disease-modifying treatments, and (4) identify objective biomarkers to improve the longitudinal tracking of impairments in clinical care and research. This article summarizes the work carried out by the task force toward identifying challenges and opportunities in the development of technologies with potential for improving the clinical management and the quality of life of individuals with PD. © 2016 International Parkinson and Movement Disorder Society.
Asunto(s)
Tecnología Biomédica/normas , Enfermedad de Parkinson/diagnóstico , Enfermedad de Parkinson/terapia , HumanosAsunto(s)
Albuminas 2S de Plantas/inmunología , Antígenos de Plantas/inmunología , Arachis/efectos adversos , Glicoproteínas/inmunología , Inmunoglobulina E/inmunología , Hipersensibilidad al Cacahuete/diagnóstico , Hipersensibilidad al Cacahuete/inmunología , Adolescente , Arachis/inmunología , Canadá , Niño , Preescolar , Femenino , Humanos , MasculinoRESUMEN
Since the conception of RNA nanotechnology (Cell, 94:147, 1998), there has been tremendous interest in its application for the functional delivery of RNA into cells. Splice-switching oligonucleotides (SSOs) are an emerging antisense drug class with the ability to therapeutically modify gene expression. A wide variety of chemical modifications have been devised to try to increase the activity and stability of SSOs. Also, as with most nucleic acid therapeutics, delivery into the cell is the major hurdle for in vivo and clinical applications. As a result, various RNA nanoparticles are being constructed for targeted delivery of therapeutics. However, it is difficult to find a practical assay to measure splice-switching activity. Here, we describe a model delivery system that can be used as a convenient, high-throughput assay to quantitatively measure the functional delivery and splicing redirection in a live human melanoma cell line.
Asunto(s)
Ensayos Analíticos de Alto Rendimiento/métodos , Melanoma/genética , Nanotecnología/métodos , ARN/genética , Empalme Alternativo/genética , Humanos , Melanoma/terapia , Nanopartículas/química , Nanopartículas/uso terapéutico , Oligonucleótidos/genética , Oligonucleótidos/uso terapéutico , ARN/uso terapéutico , Empalme del ARN/genéticaRESUMEN
Dendrimer chemistries have virtually exploded in recent years with increasing interest in this class of polymers as gene delivery vehicles. An effective nucleic acid delivery vehicle must efficiently bind its cargo and form physically stable complexes. Most importantly, the nucleic acid must be protected in biological fluids and tissues, as RNA is extremely susceptible to nuclease degradation. Here, we characterized the association of nucleic acids with generation 4 PEGylated poly(amidoamine) dendrimer (mPEG-PAMAM-G4). We investigated the formation, size, and stability over time of the nanoplexes at various N/P ratios by gel shift and dynamic light scatter spectroscopy (DLS). Further characterization of the mPEG-PAMAM-G4/nucleic acid association was provided by atomic force microscopy (AFM) and by circular dichroism (CD). Importantly, mPEG-PAMAM-G4 complexation protected RNA from treatment with RNase A, degradation in serum, and various tissue homogenates. mPEG-PAMAM-G4 complexation also significantly enhanced the functional delivery of RNA in a novel engineered human melanoma cell line with splice-switching oligonucleotides (SSOs) targeting a recombinant luciferase transcript. mPEG-PAMAM-G4 triconjugates formed between gold nanoparticle (GNP) and particularly manganese oxide (MnO) nanorods, poly IC, an anticancer RNA, showed enhanced cancer-killing activity by an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cell viability assay.
Asunto(s)
Empalme Alternativo/genética , Dendrímeros/química , Nylons/química , Oligonucleótidos/genética , Poli I-C/metabolismo , Polietilenglicoles/química , Ribonucleasa Pancreática/metabolismo , Animales , Antineoplásicos/metabolismo , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Dicroismo Circular , Dendrímeros/farmacología , Portadores de Fármacos/química , Portadores de Fármacos/farmacología , Femenino , Humanos , Melanoma/genética , Melanoma/patología , Ratones , Microscopía de Fuerza Atómica , Estructura Molecular , Nanoestructuras/química , Nylons/farmacología , Oligonucleótidos/metabolismo , Poli I-C/genética , Polietilenglicoles/farmacología , ARN/genética , ARN/metabolismo , Estabilidad del ARN/efectos de los fármacosRESUMEN
An experiment was conducted to examine the relationship between reproduction and longevity in an annual iteroparous species of grasshopper, Melanoplus sanguinipes. Two hypotheses derived from life history theory were tested. These included: 1) virgin females produce fewer eggs and live longer than mated females, and 2) the rate of egg production and longevity are negatively related. The results of this study indicated that there is no trade-off between reproduction and longevity in this species of grasshopper. It is suggested that other factors, such as male-female interactions, may be more important in affecting female survival than reproduction.